ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 19 October to 25 October 2026

The 10 most important of the 43 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Palliative and end-of-life care · Support Care Cancer · 2026-10-23

Systematic review of 34 cohort studies (27,473 patients with gastrointestinal cancers): cachexia was associated with postoperative complications (OR 1.38) and longer hospital stay (MD 2.09), not chemotherapy adverse events (OR 1.42, NS). Very low certainty evidence.

Meta-analysisn = 27,473
Furuya et al. Association between cancer cachexia and treatment-related adverse outcomes in patients with gastrointestinal cancers: a systematic review and meta-analysis
Cardiology · J Am Heart Assoc · 2026-10-23

In 4,210 participants from three US cohorts (MESA, Jackson Heart Study, WHI), higher socioeconomic status was associated with lower coronary heart disease risk (HR 0.74); 233 plasma proteins were linked to status and 21 statistically mediated the CHD association.

Meta-analysisn = 4,210
Glover et al. Role of Plasma Proteins in the Association Between Socioeconomic Status and Cardiovascular Disease Events: Results From Trans-Omics for Precision Medicine Cohorts
Addiction · Nicotine Tob Res · 2026-10-22

In a randomised experiment in 1816 US young adults, viewing positive social media videos about nicotine addiction raised adjusted odds of vaping intentions vs control videos (OR 1.49, 95% CI 1.08–2.04), but not smoking intentions; negative videos raised intent to quit smoking.

RCTn = 1,816
Marynak et al. Effects of exposure to negative and positive social media content about vaping and nicotine addiction on beliefs and intentions to use e-cigarettes among young adults in the United States: results from a randomized controlled experiment
Cardiology · EuroIntervention · 2026-10-19

Systematic review of 5 RCTs (4 meta-analysed, n=1,476) in patients with coronary disease undergoing TAVI: routine PCI vs conservative care lowered MACE (RR 0.80, 95% CI 0.65-0.98) and unplanned revascularisation but raised major bleeding (RR 1.57).

Meta-analysisn = 1,644
Bujak et al. Coronary artery disease management in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis of randomised controlled trials
Oncology · Lancet · 2026-10-24

In 970 patients with refractory metastatic colorectal cancer in Japan, a 14-day trifluridine-tipiracil plus bevacizumab schedule was non-inferior to the 28-day schedule for overall survival (median 11·3 vs 10·3 months; HR 0·93), with less grade ≥3 neutropenia (13% vs 39%).

RCTn = 970
Sakakida et al. 14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan
Palliative and end-of-life care · Support Care Cancer · 2026-10-19

Network meta-analysis of 12 RCTs (736 cancer patients): prolonged scalp hypothermia (>90 min) improved hair preservation vs usual care (RR 24.66; 95% CI 7.07–86.05) and traditional cooling (RR 2.13), but not significantly vs short. Low to very low certainty.

Meta-analysisn = 736
Boonpattharatthiti et al. Comparative efficacy of interventions for preventing chemotherapy-induced alopecia: a systematic review and network meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.